Serum IL-36β levels were not correlated with disease severity markers, such as serum lactate dehydrogenase, IgE, and CCL17 levels, eosinophil counts in peripheral blood, and the Eczema Area and Severity Index (EASI) scores. This evidence concerns the gene CCL17 and Eczematoid dermatitis.